Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Resistant Prostate Cancer”

Showing 7 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Large-scale testing (Phase 3)Study completedNCT00617669
What this trial is testing

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 1,494
Not applicableActive Not RecruitingNCT02730338
What this trial is testing

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

Who this might be right for
Metastatic Prostate Cancer
Movember Foundation 866
Not applicableWithdrawnNCT02169063
What this trial is testing

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
University of Washington
Testing effectiveness (Phase 2)Study completedNCT00473512
What this trial is testing

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Who this might be right for
Prostatic Neoplasms
Cougar Biotechnology, Inc. 54
Early research (Phase 1)Study completedNCT01664728
What this trial is testing

An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 54
Testing effectiveness (Phase 2)Study completedNCT01090765
What this trial is testing

A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate CancerMetastatic Castrate Resistant Prostate Cancer
National Cancer Institute (NCI) 21

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation